Schering-Plough enters $165M Clarinex accord

Schering-Plough Corp., the drugmaker acquired by Merck & Co., won a U.S. judge’s approval of a $165 million settlement to resolve lawsuits over alleged fraudulent statements to investors about the Clarinex allergy medicine.

Continue reading here:
Schering-Plough enters $165M Clarinex accord

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon
Sign Up For Our Email Newsletter

Over the years, through our many assignments, the Principals of Revitalization Partners frequently said to ourselves: “One day, we should write a book about our work and how we can help companies through our experiences.” This is that book and we hope that you find words of value to you and your business.

To Download Our
Corporate Capabilities Brochure